A carregar...
Duration of anticoagulant therapy and VTE recurrence in patients with cancer
PURPOSE: Anticoagulant therapy for at least 3–6 months is currently recommended for treatment of venous thromboembolism (VTE) in patients with cancer, but the optimal duration of treatment is unknown. This study examines the association between the duration of anticoagulation treatment and VTE recur...
Na minha lista:
| Publicado no: | Support Care Cancer |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6726708/ https://ncbi.nlm.nih.gov/pubmed/30734088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-019-4661-3 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|